Abstract:
PURPOSE: A VP7 antigen of African horse sickness virus(AHSV) and a diagnostic method of African horse sickness(AHS) using a monoclonal antibody therefor are provided, thereby rapidly and accurately diagnosing AHSV. CONSTITUTION: A diagnostic method of African horse sickness(AHS) using a monoclonal antibody to VP7 antigen of African horse sickness virus(AHSV) comprises the steps of: (1) adhering a monoclonal antibody for VP7 antigen of African horse sickness virus(AHSV) to a solid support; (2) binding the VP7 antigen of AHSV with the monoclonal antibody adhered to the solid support; (3) reacting a sample containing an antibody for a VP7 protein with the VP7 antigen of AHSV; (4) reacting a secondary antibody selected from the group consisting of an enzyme conjugated antibody, a radioactive material conjugated antibody and a fluorescent material conjugated antibody, with the antibody of the step 3; and (5) quantifying the antibody in the sample, wherein the monoclonal antibody for VP7 antigen of African horse sickness virus(AHSV) is produced from a hybridoma cell(KCTC 10136BP).
Abstract:
PURPOSE: A method for purifying porcine infectious coronavirus is provided, thereby the porcine infectious coronavirus can be simply and rapidly purified without losing its activity, so that it can be used in producing vaccines or diagnosis kits. CONSTITUTION: The method for purifying porcine infectious coronavirus comprises the steps of: packing the column with crosslinked polysaccharides or sulfate ester of cellulose; washing the column with TEN buffer solution(pH 7.5) consisting of 10mM of Tris, 1mM of EDTA and 100mM of sodium chloride; homogenizing the column with TEN buffer solution; passing the porcine infectious coronavirus containing solution through the column to adsorb it to the column; washing the column with TEN buffer solution; and eluting the porcine infectious coronavirus with TEN buffer solution(pH 7.5) consisting of 10mM of Tris, 1mM of EDTA and 1.0 to 3.0M of sodium chloride.
Abstract:
The present invention relates to a recombinant cell for expressing a capsid protein of swine hepatitis E virus. The present invention can be effectively used as a vaccine against swine hepatitis E virus by producing the capsid protein remarkably similar to the state of swine hepatitis E virus infection, which is difficult to artificially culture within a laboratory. Considering the difficulty in performing artificial culturing of the virus, the capsid protein can be remarkably useful in precise disease diagnosis since it can be used in a final diagnosis antibody test method.
Abstract:
PURPOSE: A porcine circovirus 2 (PCV2) capsid protein is provided to produce a large amount of antigens, to diagnose circovirus 2 capsid antibody, and to produce a vaccine. CONSTITUTION: A method for detecting a porcine circovirus antibody comprises a step of using a porcine circovirus 2 capsid protein as an antigen. The capsid protein has an amino acid sequence of sequence number 2. The amino acid sequence is encoded by a base sequence of sequence number 1. The method is performed by a fluorescent antibody test or enzyme immunoassay. A vaccine for preventing porcine circovirus 2 contains the capsid protein as an antigen.
Abstract:
PURPOSE: An immunoglobulin yolk according to a bee virus is provided to be used as a controlling method of environment-friendly bee virus by inducing an immune reaction in the bee and to replace chemical controlling method or a conventional post antigen detecting method. CONSTITUTION: A manufacturing method of immunoglobulin yol according to a bee virus comprises 1) a step of inoculating the bee virus as an antigen to an egg, 2) a step fo collecting yolk from the egg, and 3) a step of separating the immunoglobulin yolk according to the bee virus from the yolk. The inoculation is performed 0.1ml to 0.5ml for the first inoculation and for two weeks apart, 2-4 times are inoculated. A composition for the bee virus prevention comprises the bee virus immunoglobulin yolk.
Abstract:
PURPOSE: A culturing method of bee virus using a bee larva is provided to be usefully used on screening effective treatment by evaluating effect of the therapeutic agent according to the various bee virus using effectively cultured bee virus which was hard to culture in-vitro. CONSTITUTION: A culturing method of bee virus is to infect the bee virus to artificially cultivated bee larva. The articifial culturing is performed on the bee larva at 35-40 degree Celsius and 80-90% humidity. The culturing comprises 5-10% of D-glucose, 5-10% of D-fructose, 1-3% of enzyme extract, 25-35% of grace medium, and 80-100 micro liters of solution comprised of 40-50% of royal jelly. A bee virus treating material screening method using the artificially cultured larva comprises 1) a step of artificially culturing the bee larva in-vitro, 2) a step of culturing a separated bee virus to the larva from 1), and 3) a step of measuring concentration of virus after treating the bee virus therapeutic agent. [Reference numerals] (AA) Virus infected group; (BB) Thymol and chlorine dioxide treated group; (CC) Virus non-infected group; (DD) Survival rate (%); (EE) Cultivated days
Abstract:
본 발명은 수포성구내염바이러스 뉴저지형 당단백질에 결합하는 단일클론항체 및 이의 용도에 관한 것으로, 보다 자세하게는 수포성구내염바이러스 뉴저지형의 당단백질에 결합하는 단일클론항체, 이를 생산하는 융합세포주 및 상기 단일클론항체와 수포성구내염바이러스 뉴저지형의 당단백질을 이용하여 수포성구내염바이러스 뉴저지형에 특이적인 중화항체를 검출할 수 있는 수포성구내염 진단방법에 관한 것이다. 수포성구내염바이러스 뉴저지형, 단일클론항체
Abstract:
PURPOSE: A diagnostic kit for rapid detection of rabies antibodies is provided to rapidly detect the existence according to rabies vaccination within 20 minutes without expensive equipment and to reduce the generation of rabies. CONSTITUTION: A diagnostic kit for rapid detection of rabies antibodies using immunochromatography has a nitrocellulose membrane(30) containing a test line(40) and a control line(50) on a backing card(70). A conjugate pad is overlapped at one side of the nitrocellulose membrane. A sample pad(10) is overlapped on the conjugate pad. An adsorbent pad(60) absorbing blood serum in which the reaction is completed on a backing card is installed at the other side of the nitrocellulose membrane.